Prevention of the normal expansion of maternal plasma volume: A model for chronic fetal hypoxaemia

S. S. Daniel, L. S. James, R. I. Stark, P. J. Tropper

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

The effects of inadequate expansion of maternal blood volume on uterine blood flow, fetal oxygen levels and vasoactive mediators during the third trimester were studied in 8 pregnant sheep. Results were compared to those obtained during 15 normal pregnancies. Prevention of the normal (20 ml/day) increase in maternal plasma volume was achieved by repeated haemorrhage and injections of furosemide. These treatments also reduced the rise in blood flow to the pregnant uterine horn that normally occurs during this period of gestation: at term flow was only 508 ± 61 (SEM) compared to 838 ± 83 ml/min in the control group (P>0.01). This reduction in uterine blood flow caused a gradual fall in fetal PaO2, and rise in fetal levels of plasma renin activity, vasopressin, catecholamines and angiotensin II without change in pH(a) or base excess. Four to 5 days prior to delivery, the difference from control in PaO2 was -3.9 ± 0.5 mmHg, plasma renin activity +2.9 ± 1.7 ng/ml·h, vasopressin +4.2 ± 1.1 pg/ml, catecholamines +957 ± 145.3 pg/ml and angiotensin II +243 ± 108.2 pg/ml. Furthermore, the fall in PaO2 and rise in vasoactive mediators that normally occur 3-5 days prior to the onset of labour was either absent (PaO2 and plasma renin activity) or blunted. Thus when expansion of blood volume during pregnancy is inadequate, blood flow to the uterus is adversely affected. This leads to various degrees of chronic fetal hypoxaemia and stimulation of vasoactive mediator systems. However, the normal stimulation of vasoactive mediator systems that occurs 3-5 days before delivery appears to be blunted. Experimental prevention of blood volume expansion during pregnancy produces an excellent model for the study of chronic mild fetal hypoxaemia.

Original languageEnglish (US)
Pages (from-to)225-233
Number of pages9
JournalJournal of Developmental Physiology
Volume11
Issue number4
StatePublished - 1989
Externally publishedYes

Fingerprint

Plasma Volume
Blood Volume
Mothers
Renin
Pregnancy
Vasopressins
Angiotensin II
Catecholamines
Labor Onset
Furosemide
Third Pregnancy Trimester
Fetal Blood
Uterus
Sheep
Hemorrhage
Oxygen
Control Groups
Injections
Hypoxia
Therapeutics

ASJC Scopus subject areas

  • Developmental Biology
  • Physiology

Cite this

Prevention of the normal expansion of maternal plasma volume : A model for chronic fetal hypoxaemia. / Daniel, S. S.; James, L. S.; Stark, R. I.; Tropper, P. J.

In: Journal of Developmental Physiology, Vol. 11, No. 4, 1989, p. 225-233.

Research output: Contribution to journalArticle

Daniel, S. S. ; James, L. S. ; Stark, R. I. ; Tropper, P. J. / Prevention of the normal expansion of maternal plasma volume : A model for chronic fetal hypoxaemia. In: Journal of Developmental Physiology. 1989 ; Vol. 11, No. 4. pp. 225-233.
@article{605832fc36994388a4f945d5678a4fc0,
title = "Prevention of the normal expansion of maternal plasma volume: A model for chronic fetal hypoxaemia",
abstract = "The effects of inadequate expansion of maternal blood volume on uterine blood flow, fetal oxygen levels and vasoactive mediators during the third trimester were studied in 8 pregnant sheep. Results were compared to those obtained during 15 normal pregnancies. Prevention of the normal (20 ml/day) increase in maternal plasma volume was achieved by repeated haemorrhage and injections of furosemide. These treatments also reduced the rise in blood flow to the pregnant uterine horn that normally occurs during this period of gestation: at term flow was only 508 ± 61 (SEM) compared to 838 ± 83 ml/min in the control group (P>0.01). This reduction in uterine blood flow caused a gradual fall in fetal PaO2, and rise in fetal levels of plasma renin activity, vasopressin, catecholamines and angiotensin II without change in pH(a) or base excess. Four to 5 days prior to delivery, the difference from control in PaO2 was -3.9 ± 0.5 mmHg, plasma renin activity +2.9 ± 1.7 ng/ml·h, vasopressin +4.2 ± 1.1 pg/ml, catecholamines +957 ± 145.3 pg/ml and angiotensin II +243 ± 108.2 pg/ml. Furthermore, the fall in PaO2 and rise in vasoactive mediators that normally occur 3-5 days prior to the onset of labour was either absent (PaO2 and plasma renin activity) or blunted. Thus when expansion of blood volume during pregnancy is inadequate, blood flow to the uterus is adversely affected. This leads to various degrees of chronic fetal hypoxaemia and stimulation of vasoactive mediator systems. However, the normal stimulation of vasoactive mediator systems that occurs 3-5 days before delivery appears to be blunted. Experimental prevention of blood volume expansion during pregnancy produces an excellent model for the study of chronic mild fetal hypoxaemia.",
author = "Daniel, {S. S.} and James, {L. S.} and Stark, {R. I.} and Tropper, {P. J.}",
year = "1989",
language = "English (US)",
volume = "11",
pages = "225--233",
journal = "Journal of Developmental Physiology",
issn = "0141-9846",
number = "4",

}

TY - JOUR

T1 - Prevention of the normal expansion of maternal plasma volume

T2 - A model for chronic fetal hypoxaemia

AU - Daniel, S. S.

AU - James, L. S.

AU - Stark, R. I.

AU - Tropper, P. J.

PY - 1989

Y1 - 1989

N2 - The effects of inadequate expansion of maternal blood volume on uterine blood flow, fetal oxygen levels and vasoactive mediators during the third trimester were studied in 8 pregnant sheep. Results were compared to those obtained during 15 normal pregnancies. Prevention of the normal (20 ml/day) increase in maternal plasma volume was achieved by repeated haemorrhage and injections of furosemide. These treatments also reduced the rise in blood flow to the pregnant uterine horn that normally occurs during this period of gestation: at term flow was only 508 ± 61 (SEM) compared to 838 ± 83 ml/min in the control group (P>0.01). This reduction in uterine blood flow caused a gradual fall in fetal PaO2, and rise in fetal levels of plasma renin activity, vasopressin, catecholamines and angiotensin II without change in pH(a) or base excess. Four to 5 days prior to delivery, the difference from control in PaO2 was -3.9 ± 0.5 mmHg, plasma renin activity +2.9 ± 1.7 ng/ml·h, vasopressin +4.2 ± 1.1 pg/ml, catecholamines +957 ± 145.3 pg/ml and angiotensin II +243 ± 108.2 pg/ml. Furthermore, the fall in PaO2 and rise in vasoactive mediators that normally occur 3-5 days prior to the onset of labour was either absent (PaO2 and plasma renin activity) or blunted. Thus when expansion of blood volume during pregnancy is inadequate, blood flow to the uterus is adversely affected. This leads to various degrees of chronic fetal hypoxaemia and stimulation of vasoactive mediator systems. However, the normal stimulation of vasoactive mediator systems that occurs 3-5 days before delivery appears to be blunted. Experimental prevention of blood volume expansion during pregnancy produces an excellent model for the study of chronic mild fetal hypoxaemia.

AB - The effects of inadequate expansion of maternal blood volume on uterine blood flow, fetal oxygen levels and vasoactive mediators during the third trimester were studied in 8 pregnant sheep. Results were compared to those obtained during 15 normal pregnancies. Prevention of the normal (20 ml/day) increase in maternal plasma volume was achieved by repeated haemorrhage and injections of furosemide. These treatments also reduced the rise in blood flow to the pregnant uterine horn that normally occurs during this period of gestation: at term flow was only 508 ± 61 (SEM) compared to 838 ± 83 ml/min in the control group (P>0.01). This reduction in uterine blood flow caused a gradual fall in fetal PaO2, and rise in fetal levels of plasma renin activity, vasopressin, catecholamines and angiotensin II without change in pH(a) or base excess. Four to 5 days prior to delivery, the difference from control in PaO2 was -3.9 ± 0.5 mmHg, plasma renin activity +2.9 ± 1.7 ng/ml·h, vasopressin +4.2 ± 1.1 pg/ml, catecholamines +957 ± 145.3 pg/ml and angiotensin II +243 ± 108.2 pg/ml. Furthermore, the fall in PaO2 and rise in vasoactive mediators that normally occur 3-5 days prior to the onset of labour was either absent (PaO2 and plasma renin activity) or blunted. Thus when expansion of blood volume during pregnancy is inadequate, blood flow to the uterus is adversely affected. This leads to various degrees of chronic fetal hypoxaemia and stimulation of vasoactive mediator systems. However, the normal stimulation of vasoactive mediator systems that occurs 3-5 days before delivery appears to be blunted. Experimental prevention of blood volume expansion during pregnancy produces an excellent model for the study of chronic mild fetal hypoxaemia.

UR - http://www.scopus.com/inward/record.url?scp=0024421836&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024421836&partnerID=8YFLogxK

M3 - Article

C2 - 2691556

AN - SCOPUS:0024421836

VL - 11

SP - 225

EP - 233

JO - Journal of Developmental Physiology

JF - Journal of Developmental Physiology

SN - 0141-9846

IS - 4

ER -